---
figid: PMC5770599__onc2017313f2
figlink: /pmc/articles/PMC5770599/figure/fig2/
number: Figure 2
caption: Regulation of Wnt/β-catenin signaling and oncogenic NF-κB pathway by ubiquitylating
  enzymes in CRC. Transmembrane E3 ligases RNF43 and ZNRF3 utilize disheveled segment
  polarity protein (DVL) as an adaptor to induce the endocytosis of Frizzled–LRP5/6
  complex and abrogation of Wnt signaling. Binding of Wnt proteins to Wnt receptors
  results in the inactivation of GSK3β. β-catenin remains unphosphorylated, and it
  translocates to the nucleus where it binds to the LEF/TCF transcription complex,
  activating Wnt/β-catenin downstream target gene transcription. In the absence of
  Wnt, the scaffolding protein AXIN assembles a multiprotein destruction complex that
  consists of β-catenin, APC and GSK3β. β-catenin is phosphorylated by GSK3β and recognized
  by SCF-β-TrCP, leading to ubiquitylation and degradation of β-catenin. XIAP induces
  monoubiquitylation of TLE and releases TLE from the TCF/LEF complex, thereby initiating
  a canonical Wnt transcriptional program in CRC. K63-linked ubiquitylation of TRAF6
  leads to the recruitment of the IKK (IκB kinase) complex (α, β, γ) and activation
  of IKK through TRAF6-mediated polyubiquitination. Activation of IKK kinase complex
  results in SCF-β-TrCP-mediated ubiquitination and proteasomal degradation of IκB
  (inhibitor of NF-κB kinase), thereby enabling the translocation of p50 and p65 to
  the nucleus and induction of NF-κB target genes, leading to positive regulation
  of NF-κB signaling. FBW7 preferentially targets phosphorylated JUN both by GSK3β
  or JNK and promotes JUN degradation in the proteasome. Accordingly, FBW7 depletion
  results in accumulation of phosphorylated JUN and stimulation of AP-1 activity.
  AP-1, activator protein 1; AXIN, axis inhibition protein; DVL, disheveled segment
  polarity protein; FBW7, F-box and WD repeat domain-containing 7; GSK3β, glycogen
  synthase kinase-3 beta; JUN, AP-1 transcription factor subunit; LEF/TCF, lymphoid
  enhancer factor/T-cell factor; LRP5/6, low-density lipoprotein receptor-related
  protein 5/6; TRAF6, tumor necrosis factor receptor-associated factor; XIAP, X-chromosome-linked
  inhibitor of apoptotic proteins.
pmcid: PMC5770599
papertitle: Functional significance and therapeutic implication of ring-type E3 ligases
  in colorectal cancer.
reftext: L Liu, et al. Oncogene. 2018 Jan 11;37(2):148-159.
pmc_ranked_result_index: '130646'
pathway_score: 0.9647957
filename: onc2017313f2.jpg
figtitle: Regulation of Wnt/Beta-catenin signaling and oncogenic NFKB pathway by ubiquitylating
  enzymes in CRC
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5770599__onc2017313f2.html
  '@type': Dataset
  description: Regulation of Wnt/β-catenin signaling and oncogenic NF-κB pathway by
    ubiquitylating enzymes in CRC. Transmembrane E3 ligases RNF43 and ZNRF3 utilize
    disheveled segment polarity protein (DVL) as an adaptor to induce the endocytosis
    of Frizzled–LRP5/6 complex and abrogation of Wnt signaling. Binding of Wnt proteins
    to Wnt receptors results in the inactivation of GSK3β. β-catenin remains unphosphorylated,
    and it translocates to the nucleus where it binds to the LEF/TCF transcription
    complex, activating Wnt/β-catenin downstream target gene transcription. In the
    absence of Wnt, the scaffolding protein AXIN assembles a multiprotein destruction
    complex that consists of β-catenin, APC and GSK3β. β-catenin is phosphorylated
    by GSK3β and recognized by SCF-β-TrCP, leading to ubiquitylation and degradation
    of β-catenin. XIAP induces monoubiquitylation of TLE and releases TLE from the
    TCF/LEF complex, thereby initiating a canonical Wnt transcriptional program in
    CRC. K63-linked ubiquitylation of TRAF6 leads to the recruitment of the IKK (IκB
    kinase) complex (α, β, γ) and activation of IKK through TRAF6-mediated polyubiquitination.
    Activation of IKK kinase complex results in SCF-β-TrCP-mediated ubiquitination
    and proteasomal degradation of IκB (inhibitor of NF-κB kinase), thereby enabling
    the translocation of p50 and p65 to the nucleus and induction of NF-κB target
    genes, leading to positive regulation of NF-κB signaling. FBW7 preferentially
    targets phosphorylated JUN both by GSK3β or JNK and promotes JUN degradation in
    the proteasome. Accordingly, FBW7 depletion results in accumulation of phosphorylated
    JUN and stimulation of AP-1 activity. AP-1, activator protein 1; AXIN, axis inhibition
    protein; DVL, disheveled segment polarity protein; FBW7, F-box and WD repeat domain-containing
    7; GSK3β, glycogen synthase kinase-3 beta; JUN, AP-1 transcription factor subunit;
    LEF/TCF, lymphoid enhancer factor/T-cell factor; LRP5/6, low-density lipoprotein
    receptor-related protein 5/6; TRAF6, tumor necrosis factor receptor-associated
    factor; XIAP, X-chromosome-linked inhibitor of apoptotic proteins.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT5A
  - WNT6
  - IL1B
  - IL6
  - WNT7A
  - WNT7B
  - WNT2B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT5B
  - WNT3A
  - TLE7
  - TLE1
  - TLE2
  - TLE4
  - TLE6
  - WNT16
  - TNF
  - IL1A
  - TRAF6
  - WNT4
  - ZNRF3
  - KITLG
  - TLE3
  - AXIN2
  - CTNNB1
  - BTRC
  - CCND1
  - WNT8A
  - FZD5
  - WNT10B
  - WNT11
  - FBXW7
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD8
  - FZD9
  - FZD7
  - WNT8B
  - XIAP
  - JUN
  - GSK3B
  - LRP6
  - LRP5
  - NFKB1
  - RNF43
  - WNT1
  - WNT2
  - WNT3
  - AXIN1
  - APC
  - DVL2
  - FZD10
  - FZD2
  - MYC
  - DVL1
  - DVL3
  - IKBKG
  - Cancer
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: TNF,IL-6,IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: TNF,IL-6,IL-1
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE7
  entrez: '102723796'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE1
  entrez: '7088'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE2
  entrez: '7089'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE4
  entrez: '7091'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE6
  entrez: '79816'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: TNF,IL-6,IL-1
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNF,IL-6,IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: RNF43/ZNRF3
  symbol: ZNRF3
  source: hgnc_symbol
  hgnc_symbol: ZNRF3
  entrez: '84133'
- word: SCF
  symbol: SCF
  source: hgnc_alias_symbol
  hgnc_symbol: KITLG
  entrez: '4254'
- word: TLE
  symbol: TLE
  source: bioentities_symbol
  hgnc_symbol: TLE3
  entrez: '7090'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-TRCP
  symbol: betaTrCP
  source: hgnc_alias_symbol
  hgnc_symbol: BTRC
  entrez: '8945'
- word: C-myc,c-jun,cyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: FBW7
  symbol: FBW7
  source: hgnc_alias_symbol
  hgnc_symbol: FBXW7
  entrez: '55294'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: XIAP
  symbol: XIAP
  source: hgnc_symbol
  hgnc_symbol: XIAP
  entrez: '331'
- word: C-myc,c-jun,cyclinD1
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: GSK-3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: LRP5/6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: LRP5/6
  symbol: LRP5
  source: hgnc_symbol
  hgnc_symbol: LRP5
  entrez: '4041'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: RNF43/ZNRF3
  symbol: RNF43
  source: hgnc_symbol
  hgnc_symbol: RNF43
  entrez: '54894'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Axin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: C-myc,c-jun,cyclinD1
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL1
  entrez: '1855'
- word: DVL
  symbol: DVL
  source: bioentities_symbol
  hgnc_symbol: DVL3
  entrez: '1857'
- word: JUN
  symbol: JUN
  source: hgnc_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: IKKY
  symbol: IKK-gamma
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
